Cargando…
Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone
Purpose. In a previous series of 25 human osteosarcoma samples studied for MYC gene amplification, we found amplification in two cases (8%), including one arising in association with Paget's disease (pagetic osteosarcoma). Based on this observation, we further investigated the prevalence of MYC...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395365/ https://www.ncbi.nlm.nih.gov/pubmed/18521214 http://dx.doi.org/10.1080/13577149778209 |
_version_ | 1782155489271873536 |
---|---|
author | Ueda, Takafumi Healey, John H. Huvos, Andrew G. Ladanyi, Marc |
author_facet | Ueda, Takafumi Healey, John H. Huvos, Andrew G. Ladanyi, Marc |
author_sort | Ueda, Takafumi |
collection | PubMed |
description | Purpose. In a previous series of 25 human osteosarcoma samples studied for MYC gene amplification, we found amplification in two cases (8%), including one arising in association with Paget's disease (pagetic osteosarcoma). Based on this observation, we further investigated the prevalence of MYC gene amplification in pagetic osteosarcomas. Methods. MYC gene amplification was assessed by Southern blot analysis using frozen tissue samples in five cases of pagetic osteosarcoma and 53 cases of primary (non-pagetic) osteosarcoma. Amplification was considered present if the MYC copy number was six or greater. Results. Three out of five patients (60%) with pagetic osteosarcoma showed MYC gene amplification, whereas it was present in only 5/53 patients (9.4%) with primary osteosarcoma. The incidence of MYC amplification in pagetic osteosarcoma was thus significantly higher than that in primary osteosarcoma (p = 0.016). Discussion. The finding that MYC gene amplification may be more common in pagetic than primary osteosarcoma warrants further study and suggests pathogenetic differences between primary osteosarcomas and those arising in the setting of Paget's disease. Three of the four pagetic osteosarcomas from the present study were previously shown to be immunoreactive for p53, suggesting that p53 mutation may also be a frequent genetic lesion in these tumors. |
format | Text |
id | pubmed-2395365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-23953652008-06-02 Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone Ueda, Takafumi Healey, John H. Huvos, Andrew G. Ladanyi, Marc Sarcoma Research Article Purpose. In a previous series of 25 human osteosarcoma samples studied for MYC gene amplification, we found amplification in two cases (8%), including one arising in association with Paget's disease (pagetic osteosarcoma). Based on this observation, we further investigated the prevalence of MYC gene amplification in pagetic osteosarcomas. Methods. MYC gene amplification was assessed by Southern blot analysis using frozen tissue samples in five cases of pagetic osteosarcoma and 53 cases of primary (non-pagetic) osteosarcoma. Amplification was considered present if the MYC copy number was six or greater. Results. Three out of five patients (60%) with pagetic osteosarcoma showed MYC gene amplification, whereas it was present in only 5/53 patients (9.4%) with primary osteosarcoma. The incidence of MYC amplification in pagetic osteosarcoma was thus significantly higher than that in primary osteosarcoma (p = 0.016). Discussion. The finding that MYC gene amplification may be more common in pagetic than primary osteosarcoma warrants further study and suggests pathogenetic differences between primary osteosarcomas and those arising in the setting of Paget's disease. Three of the four pagetic osteosarcomas from the present study were previously shown to be immunoreactive for p53, suggesting that p53 mutation may also be a frequent genetic lesion in these tumors. Hindawi Publishing Corporation 1997-12 /pmc/articles/PMC2395365/ /pubmed/18521214 http://dx.doi.org/10.1080/13577149778209 Text en Copyright © 1997 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ueda, Takafumi Healey, John H. Huvos, Andrew G. Ladanyi, Marc Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone |
title | Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone |
title_full | Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone |
title_fullStr | Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone |
title_full_unstemmed | Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone |
title_short | Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone |
title_sort | amplification of the myc gene in osteosarcoma secondary to paget's disease of bone |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395365/ https://www.ncbi.nlm.nih.gov/pubmed/18521214 http://dx.doi.org/10.1080/13577149778209 |
work_keys_str_mv | AT uedatakafumi amplificationofthemycgeneinosteosarcomasecondarytopagetsdiseaseofbone AT healeyjohnh amplificationofthemycgeneinosteosarcomasecondarytopagetsdiseaseofbone AT huvosandrewg amplificationofthemycgeneinosteosarcomasecondarytopagetsdiseaseofbone AT ladanyimarc amplificationofthemycgeneinosteosarcomasecondarytopagetsdiseaseofbone |